The ENPP5 antibody is typically produced in rabbit hosts as either polyclonal or recombinant monoclonal antibodies. Key structural features include:
Reactivity: Cross-reacts with human, mouse, and rat samples .
Applications: Validated for Western blot (WB), immunohistochemistry (IHC), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA) .
Epitope: Targets regions such as the C-terminal domain or unmodified protein sequences .
| Supplier | Antibody Type | Applications | Reactivity | Citations |
|---|---|---|---|---|
| Abcam | Rabbit Recombinant | WB, ICC, IF | Hu, Ms, Rt | 1 |
| Biocompare | Rabbit Polyclonal | WB, ELISA, IHC | Hu, Ms, Rt | – |
| Sigma-Aldrich | Rabbit Polyclonal | IHC, WB | Hu | – |
ENPP5 expression is analyzed in cancer through immunohistochemistry and Kaplan-Meier survival plots. High expression correlates with unfavorable prognosis in certain cancers (e.g., colorectal, breast) . The Human Protein Atlas reports protein expression in 20 cancer types, with representative images for tissues like colorectal and prostate cancer .
ENPP5 hydrolyzes NAD but lacks lysophospholipase D activity . Its role in neurotransmission is suggested by its ability to cleave NAD, a critical molecule in cellular energy metabolism .
N-glycosylation has been identified as a key modification of the ENPP5 protein .
Tissue Staining: Used in paraffin-embedded sections of normal and cancer tissues (e.g., brain, breast) .